Rampart Investment Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-1,370
| Closed | -$157K | – | 392 |
|
|
2020
Q3 | $157K | Sell |
1,370
-3,121
| -69% | -$358K | 0.1% | 204 |
|
|
2020
Q2 | $504K | Buy |
4,491
+1,234
| +38% | +$138K | 0.08% | 255 |
|
|
2020
Q1 | $292K | Buy |
3,257
+634
| +24% | +$56.8K | 0.14% | 151 |
|
|
2019
Q4 | $284K | Buy |
2,623
+91
| +4% | +$9.85K | 0.03% | 401 |
|
|
2019
Q3 | $248K | Sell |
2,532
-64
| -2% | -$6.27K | 0.03% | 401 |
|
|
2019
Q2 | $340K | Sell |
2,596
-128
| -5% | -$16.8K | 0.04% | 364 |
|
|
2019
Q1 | $368K | Buy |
2,724
+334
| +14% | +$45.1K | 0.04% | 363 |
|
|
2018
Q4 | $233K | Sell |
2,390
-1,986
| -45% | -$194K | 0.06% | 239 |
|
|
2018
Q3 | $608 | Sell |
4,376
-4,226
| -49% | -$587 | ﹤0.01% | 498 |
|
|
2018
Q2 | $1.07M | Buy |
8,602
+5,033
| +141% | +$625K | 0.1% | 258 |
|
|
2018
Q1 | $398K | Buy |
+3,569
| New | +$398K | 0.04% | 366 |
|
|
2017
Q4 | – | Sell |
-3,076
| Closed | -$432K | – | 519 |
|
|
2017
Q3 | $432K | Buy |
3,076
+112
| +4% | +$15.7K | 0.15% | 163 |
|
|
2017
Q2 | $361K | Buy |
2,964
+2,340
| +375% | +$285K | 0.13% | 182 |
|
|
2017
Q1 | $76K | Sell |
624
-3,843
| -86% | -$468K | 0.03% | 186 |
|
|
2016
Q4 | $546K | Sell |
4,467
-14
| -0.3% | -$1.71K | 0.2% | 93 |
|
|
2016
Q3 | $550K | Buy |
+4,481
| New | +$550K | 0.21% | 100 |
|